A detailed history of Swiss National Bank transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Swiss National Bank holds 108,800 shares of SWTX stock, worth $3.93 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
108,800
Previous 108,800 -0.0%
Holding current value
$3.93 Million
Previous $4.1 Million 14.96%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$36.06 - $47.62 $591,384 - $780,968
16,400 Added 17.75%
108,800 $4.1 Million
Q4 2023

Feb 06, 2024

BUY
$18.94 - $37.24 $318,192 - $625,632
16,800 Added 22.22%
92,400 $3.37 Million
Q3 2023

Nov 08, 2023

BUY
$23.12 - $31.38 $16,184 - $21,966
700 Added 0.93%
75,600 $1.75 Million
Q2 2023

Aug 09, 2023

BUY
$23.15 - $32.71 $20,835 - $29,439
900 Added 1.22%
74,900 $1.96 Million
Q1 2023

May 10, 2023

BUY
$24.97 - $34.05 $209,748 - $286,020
8,400 Added 12.8%
74,000 $1.9 Million
Q4 2022

Feb 08, 2023

BUY
$21.73 - $28.72 $26,076 - $34,464
1,200 Added 1.86%
65,600 $1.71 Million
Q3 2022

Nov 09, 2022

BUY
$24.1 - $39.66 $14,460 - $23,795
600 Added 0.94%
64,400 $1.84 Million
Q2 2022

Aug 09, 2022

BUY
$18.36 - $60.07 $315,792 - $1.03 Million
17,200 Added 36.91%
63,800 $1.57 Million
Q1 2022

May 09, 2022

BUY
$48.97 - $65.46 $166,498 - $222,563
3,400 Added 7.87%
46,600 $2.63 Million
Q2 2021

Aug 06, 2021

SELL
$67.45 - $85.63 $94,430 - $119,882
-1,400 Reduced 3.14%
43,200 $3.56 Million
Q1 2021

May 07, 2021

BUY
$65.1 - $93.59 $91,139 - $131,026
1,400 Added 3.24%
44,600 $3.28 Million
Q4 2020

Feb 05, 2021

BUY
$48.36 - $77.92 $677,040 - $1.09 Million
14,000 Added 47.95%
43,200 $3.13 Million
Q3 2020

Nov 09, 2020

BUY
$36.14 - $51.99 $14,456 - $20,796
400 Added 1.39%
29,200 $1.39 Million
Q2 2020

Aug 05, 2020

BUY
$22.98 - $48.57 $661,824 - $1.4 Million
28,800 New
28,800 $1.21 Million

Others Institutions Holding SWTX

About SpringWorks Therapeutics, Inc.


  • Ticker SWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,401,100
  • Market Cap $2.26B
  • Description
  • SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...
More about SWTX
Track This Portfolio

Track Swiss National Bank Portfolio

Follow Swiss National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.